Research map: Translational PBPK modeling and model-informed drug development of IDH305, a complex CYP3A4 modulator

Back to the article

Papers in this map

  1. The Prediction of Human Pharmacokinetic Parameters from Preclinical and In Vitro Metabolism Data · Ronald Scott Obach · 1997 · 980 citations · Cited by this paper
  2. Formulation development and evaluation of nasal in situ gel of promethazine hydrochloride- part II: Pharmacokinetic evaluation and bioavailability studies · 2026 · Related
  3. Predicting the impact of physiological and biochemical processes on oral drug bioavailability · Balaji M. Agoram · 2001 · 658 citations · Cited by this paper
  4. From particle to performance: Linking size-dependent swelling to disintegration mechanisms in natural plant product tablets · 2026 · Related
  5. BDDCS Applied to Over 900 Drugs · Leslie Z. Benet · 2011 · 630 citations · Cited by this paper
  6. Perfluorocarbon–liquid interface culture method enhances mucus production and allows evaluation of drug permeability through the mucus layer · 2026 · Related
  7. Physiologically based pharmacokinetic modeling in drug discovery and development: A pharmaceutical industry perspective · HM Jones · 2015 · 487 citations · Cited by this paper
  8. In-die compressibility as a surrogate for lubrication-induced changes in tabletability · 2026 · Related
  9. Trend Analysis of a Database of Intravenous Pharmacokinetic Parameters in Humans for 670 Drug Compounds · Ronald Scott Obach · 2008 · 462 citations · Cited by this paper
  10. Rational design, expression and refolding of a novel bispecific antibody to simultaneously target VEGF-A and Ang-2 for inhibition of angiogenesis · 2026 · Related
  11. A compartmental absorption and transit model for estimating oral drug absorption · Lawrence X. Yu · 1999 · 461 citations · Cited by this paper
  12. Efficacy of ultraviolet irradiation of pharmaceutical excipients in mitigating N-nitrosamine generation · 2026 · Related
  13. Physiologically Based Pharmacokinetic Model Qualification and Reporting Procedures for Regulatory Submissions: A Consortium Perspective · Mohamad Shebley · 2018 · 391 citations · Cited by this paper
  14. Elucidation of intermolecular interaction patterns in quaternary solid dispersion complexes of enzalutamide · 2026 · Related
  15. Prediction of Intestinal First-Pass Drug Metabolism · Jiansong Yang · 2007 · 366 citations · Cited by this paper
  16. Niclosamide ethanolamine induces malignant phyllodes tumor cell death via mTOR-TFEB axis-mediated lysosomal biogenesis and functional uncoupling · 2026 · Related
  17. Transport approaches to the biopharmaceutical design of oral drug delivery systems: prediction of intestinal absorption · Lawrence X. Yu · 1996 · 339 citations · Cited by this paper
  18. Correlation between protein-polydimethylsiloxane visible particle formation and computationally derived antibody surface properties · 2026 · Related
  19. Prediction of Human Pharmacokinetics From Preclinical Information: Comparative Accuracy of Quantitative Prediction Approaches · Natilie A. Hosea · 2009 · 302 citations · Cited by this paper
  20. Identification of a diastereomer of penicilloic acid during acid-mediated degradation of 6-aminopenicillanic acid · 2026 · Related
  21. Combining the ‘bottom up’ and ‘top down’ approaches in pharmacokinetic modelling: fitting PBPK models to observed clinical data · Nikolaos Tsamandouras · 2013 · 250 citations · Cited by this paper
  22. PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 3: Comparative assessement of prediction methods of human clearance · Barbara J. Ring · 2011 · 204 citations · Cited by this paper
  23. Physiologically Based Pharmacokinetic Modelling for First-In-Human Predictions: An Updated Model Building Strategy Illustrated with Challenging Industry Case Studies · Neil A. Miller · 2019 · 142 citations · Cited by this paper
  24. PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 2: Comparative assessment of prediction methods of human volume of distribution · Rhys D. O. Jones · 2011 · 139 citations · Cited by this paper
  25. The Mechanism-Based Inactivation of CYP3A4 by Ritonavir: What Mechanism? · Nancy H.C. Loos · 2022 · 128 citations · Cited by this paper
  26. Discovery and Evaluation of Clinical Candidate IDH305, a Brain Penetrant Mutant IDH1 Inhibitor · Young Shin Cho · 2017 · 120 citations · Cited by this paper
  27. Dissolution and Translational Modeling Strategies Toward Establishing an In Vitro-In Vivo Link—a Workshop Summary Report · Tycho Heimbach · 2019 · 108 citations · Cited by this paper
  28. Use of Physiologically Based Pharmacokinetic (PBPK) Modeling for Predicting Drug-Food Interactions: an Industry Perspective · Arian Emami Riedmaier · 2020 · 99 citations · Cited by this paper
  29. A Phase I Study of IDH305 in Patients with Advanced Malignancies Including Relapsed/Refractory AML and MDS That Harbor IDH1R132 Mutations · Courtney Denton Dinardo · 2016 · 60 citations · Cited by this paper
  30. Prospective Predictions of Human Pharmacokinetics for Eighteen Compounds · Tao Zhang · 2015 · 56 citations · Cited by this paper
  31. A phase 1 study of IDH305 in patients with IDH1R132-mutant acute myeloid leukemia or myelodysplastic syndrome · Courtney Denton Dinardo · 2022 · 39 citations · Cited by this paper
  32. The effects of portal shunts on intestinal cytochrome P450 3A activity · Amin Rostami‐Hodjegan · 2002 · 37 citations · Cited by this paper
  33. The impact of gastric pH, volume, and emptying on the food effect of ziprasidone oral absorption · Steven C. Sutton · 2017 · 37 citations · Cited by this paper
  34. Practical Anticipation of Human Efficacious Doses and Pharmacokinetics Using In Vitro and Preclinical In Vivo Data · Tycho Heimbach · 2009 · 35 citations · Cited by this paper
  35. Prediction of human drug clearance from animal data: Application of the rule of exponents and ‘fu corrected intercept method’ (FCIM) · Iftekhar Mahmood · 2006 · 34 citations · Cited by this paper
  36. A comparative study of allometric scaling with plasma concentrations predicted by species-invariant time methods · Iftekhar Mahmood · 1999 · 34 citations · Cited by this paper
  37. In Vitro Dissolution Profiles Similarity Assessment in Support of Drug Product Quality: What, How, When—Workshop Summary Report · Sandra Suarez‐Sharp · 2020 · 33 citations · Cited by this paper
  38. PBBM Considerations for Base Models, Model Validation, and Application Steps: Workshop Summary Report · Tycho Heimbach · 2024 · 29 citations · Cited by this paper
  39. Defining Human Pathways of Drug Metabolism In Vivo through the Development of a Multiple Humanized Mouse Model · Nico Scheer · 2015 · 25 citations · Cited by this paper

Source: OpenAlex (CC0)